Standout Papers

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme 2007 2026 2013 2019 1.0k
  1. Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme (2007)
    James J. Vredenburgh, Annick Desjardins et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 15 from Science/Nature 96 standout
Sub-graph 1 of 20

Citing Papers

Gel/hydrogel‐based in situ biomaterial platforms for cancer postoperative treatment and recovery
2023 Standout
What is cancer metabolism?
2023 Standout
1 intermediate paper

Works of Jennifer Marcello being referenced

Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan
2008
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout

Author Peers

Author Last Decade Papers Cites
Jennifer Marcello 1934 646 871 906 34 3.0k
R. Rampling 1302 488 551 666 29 2.1k
Urs M. Lütolf 1090 670 707 1328 50 3.4k
Mario Ermani 2578 380 914 1285 57 3.5k
Marc Frénay 2782 713 1036 1407 62 4.0k
April F. Eichler 984 1067 678 1201 33 2.6k
Guy Owens 1968 375 486 1146 46 2.9k
Nils D. Arvold 1048 1316 600 1486 67 3.3k
Jane Huang 2207 980 699 1043 88 4.0k
Mark G. Malkin 1752 615 407 1194 70 3.2k
Björn Tavelin 827 1169 975 1263 68 3.6k

All Works

Loading papers...

Rankless by CCL
2026